Study explores impact of market shaping on maternal health supplies
8th April 2016
Nearly 40 percent of all maternal deaths could be prevented by greater access to just three maternal health supplies (MHS): magnesium sulphate, misoprostol, and oxytocin. In a newly published study commissioned by the Coalition, partner organization Results for Development (R4D) explores the role effective market shaping could play in making these supplies more affordable, safer, and ultimately more accessible to all who need them. By focusing its work on three diverse country contexts: Nigeria, Ethiopia and Bangladesh, the study draws on input from relevant supply- and demand-side actors to map the MHS market. It then identifies gaps and opportunities as a basis for recommending future market shaping interventions. The report can be downloaded here.
Categories: Maternal Health Supplies Caucus